Drugmaker Alembic Pharma posts earnings dip on Indian labour code changes

Feb 5 (Reuters) - Indian drugmaker Alembic Pharmaceuticals on Thursday reported lower third‑quarter profit on Thursday after ...

Alembic to skip first wave of global semaglutide launches, eyes India

Alembic Pharmaceuticals will miss the first wave of global generic semaglutide launches but is evaluating entry into the ...
CNBCTV18

Alembic Pharma secures USFDA final nod for Parkinson’s therapy tablets

With this approval, Alembic’s cumulative ANDA approvals from the USFDA now stand at 234, comprising 214 final approvals and ...

Neutral Alembic Pharma; target of Rs 860: Motilal Oswal

Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 860 in its research report dated5, 2026.
CNBCTV18

Alembic Pharma Q3 Results: Topline up 11%, margins hold; India, US markets post 6% growth

Alembic Pharmaceuticals posted double-digit revenue growth in Q3, with margins steady, though a one-time labour code ...

Alembic Pharma pivots to US branded market, set to launch women's 'health antibiotic'

The company’s decision to enter the branded US segment is driven by sustained price pressure in generics, managing director ...

Alembic Pharma shares slide 4% on Q3 profit miss; is it a good time to buy?

Analysts at Motilal Oswal Financial Services (MOFSL) have retained their Neutral rating on Alembic Pharma, with a target price of ₹860 per share ...

Alembic Pharma gets U.S. FDA nod for generic Parkinson’s drug

Alembic Pharmaceuticals has received U.S. Food and Drug Administration final approval for its abbreviated new drug application for Carbidopa, Levodopa and Entacapone Tablets in different strengths.
TMCnet

Global Tech Giant Leases 2.4 Mn Sq. Ft. Office Space in Alembic City, Bengaluru

Alembic Real Estate is part of the 118-year legacy of the Alembic Group, with a diversified presence spanning pharmaceuticals ...